Introduction to Meditinib 400mg Tablet
Meditinib 400mg Tablet is classified within the drug category called tyrosine kinase inhibitors and is primarily prescribed for the management of specific cancers. It's necessary to stick to the advised dosage and duration for maximum effectiveness.
This drug functions by targeting certain proteins called tyrosine kinases, which aid in the proliferation of cancer cells. By disrupting these proteins, Imatinib assists in regulating the proliferation and segregation of cancer cells, playing a valuable role in the management of multiple cancer types.
Patients have the option to consume it with meals or on an empty stomach,, but it's beneficial to take it at a regular time each day for enhanced results.
The treatment may produce a variety of negative reactions, such as fluid retention, extreme tiredness, skin hives, high temperature, alopecia, sleep disturbances, aches in the joints, muscle pains, increase in body weight, nocturnal sweating, itchiness, adverse effects on the digestive system, blood cell irregularities, damage to the liver, and kidney toxicity. Although some of these adverse reactions are standard, any serious or lingering conditions should be reported to the healthcare professional immediately.
The treatment might result in a condition known as tumor lysis syndrome, particularly in patients with a substantial quantity of tumor cells. Regular checks and preventive actions are vital to manage this possible risk. In parallel, if anyone endures severe or continuous muscle or skeletal discomfort or contractions, they should seek out medical help immediately.
Should a dosage be overlooked, it should be taken as soon as remembered. If the subsequent scheduled dosage is near, the omitted dosage shouldn't be doubled. It's wise to reach out to the prescribing doctor for tips on how to effectively handle missed doses.
![Meditinib 400mg Tablet](https://storage.googleapis.com/dawaadost.appspot.com/dd_products/1706189760012_POS2714dawaadost_image.webp)
How Meditinib 400mg Tablet Works?
In a more substantial dose, Meditinib 400mg Tablet retains its designation as a tyrosine kinase inhibitor, proficiently managing aberrant protein performance in cancer cells. This enhanced dosage is typically advised at evolved phases of certain cancers, ensuring sustained impediment of tumor advancement and escalation for better clinical results.
How To Use Meditinib 400mg Tablet
- Adhere to your physicians' instructions for this medication, consuming it in the instructed dosage and period.
- You can consume this medication with or without meals, but sustaining a uniform time every day is encouraged for improved outcomes.
- Ingest the medication wholly; refrain from chewing, pulverizing, or fracturing it.
Special Precautions About Meditinib 400mg Tablet
- Imatinib treatment may lead to tumour lysis syndrome, especially in individuals with high tumour burden. Monitoring and preventative measures should be implemented to manage this risk.
- Imatinib may cause musculoskeletal pain or cramps. Individuals experiencing severe or persistent pain should seek medical attention.
Benefits Of Meditinib 400mg Tablet
- Manages gastrointestinal stromal tumours.
- Inhibits cancer cell growth.
Side Effects Of Meditinib 400mg Tablet
- Edema (swelling)
- Fatigue
- Rash
- Fever
- Hair loss
- Insomnia (difficulty in sleeping)
- Joint pain
- Muscle pain
- Weight gain
- Night sweats
- Itching
- Gastrointestinal toxicity
- Blood cell abnormalities
- Liver toxicity, Renal toxicity
What If I Missed A Dose Of Meditinib 400mg Tablet
FAQS
Similar Medicine Of Meditinib 400mg Tablet
For information purposes only. Consult a doctor before taking any medicines.
GLS Pharma Ltd.
Biochem Pharmaceutical Industries
Cipla Ltd
Novartis India Ltd
Natco Pharma Ltd
Celon Laboratories Ltd
Alkem Laboratories Ltd
Mylan Pharmaceuticals Pvt Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Safety Advice For Meditinib 400mg Tablet
check for risk indication explain below.
- High risk
- Moderate risk
- Safe
Alcohol
Consult your healthcare provider for advice on the safety of alcohol consumption while on Meditinib 400mg Tablet.
Pregnancy
It's unsafe to use Meditinib 400mg Tablet during pregnancy because of potential risks to the unborn baby. Please seek advice from your doctor.
Breast feeding
Caution is advised when breastfeeding while using Meditinib 400mg Tablet, as it could potentially harm the baby. Avoid nursing during therapy and for 15 days after discontinuation.
Kidney
For people with kidney disease, Meditinib 400mg Tablet should be used with caution. Your doctor may advise on possible dosage alterations and supervision.
Liver
People with severe liver conditions should be careful with Meditinib 400mg Tablet. Adjustments on dosage might be needed. Consult your physician for personalized recommendations.
Alcohol
Consult your healthcare provider for advice on the safety of alcohol consumption while on Meditinib 400mg Tablet.
Pregnancy
It's unsafe to use Meditinib 400mg Tablet during pregnancy because of potential risks to the unborn baby. Please seek advice from your doctor.
Breast feeding
Caution is advised when breastfeeding while using Meditinib 400mg Tablet, as it could potentially harm the baby. Avoid nursing during therapy and for 15 days after discontinuation.
Kidney
For people with kidney disease, Meditinib 400mg Tablet should be used with caution. Your doctor may advise on possible dosage alterations and supervision.
Liver
People with severe liver conditions should be careful with Meditinib 400mg Tablet. Adjustments on dosage might be needed. Consult your physician for personalized recommendations.
Disease Explanation
![thumbnail.sv](https://storage.googleapis.com/dawaadost.appspot.com/main_images/3c02a2e8-0af9-4acb-9bab-c73055f21445_resize.webp)
Chronic Myeloid Leukemia (CML): A type of blood cancer that originates in the bone marrow, specifically affecting the white blood cells. CML is characterized by the overproduction of abnormal white blood cells called granulocytes. It often progresses slowly and can be managed with targeted therapies. Acute Lymphocytic Leukemia (ALL): Another type of blood cancer that primarily affects the white blood cells, specifically lymphocytes. ALL is characterized by the rapid and uncontrolled proliferation of immature lymphocytes. It is an aggressive form of leukemia that requires prompt treatment, typically with chemotherapy. Gastrointestinal Stromal Tumor (GIST): A rare type of tumor that originates in the gastrointestinal tract, most commonly in the stomach or small intestine. GISTs are usually non-cancerous (benign), but some can be cancerous (malignant). They are often treated with surgery and, in some cases, targeted therapy to inhibit specific molecular pathways involved in their growth.
Update on: Saturday, 17 Feburary, 2024
Written By:
Nitish Chauhan